Development of Miltefosine for the Leishmaniases
- 1 February 2006
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Mini-Reviews in Medicinal Chemistry
- Vol. 6 (2) , 145-151
- https://doi.org/10.2174/138955706775475993
Abstract
The leishmaniases consist of visceral and cutaneous syndromes present in > 30 endemic regions of the world. Miltefosine (hexadecylephosphocholine) is the first oral agent that is effective and tolerated for both visceral and cutaneous disease in several endemic regions, and represents a major advance in the treatment of these diseases.Keywords
This publication has 0 references indexed in Scilit: